WEBINAR – Analysis of Monoclonal Antibody Aggregates Using ArgusEye’s Nanoplasmonic Sensing Technology
WEBINAR - Analysis of Monoclonal Antibody Aggregates Using ArgusEye’s Nanoplasmonic [...]
WEBINAR – Enhancing Antibody Process Development: Real-Time Monitoring of Downstream Processing with the AugaOne™ Sensor System
WEBINAR - Enhancing Antibody Process Development: Real-Time Monitoring of Downstream [...]
Webinar Series Launching This Febuary
Webinar Series Launching This Febuary [...]
ArgusEye Makes It On ’33-Listan’ for the Third Time – Achieves ‘Gold Company’ Status
ArgusEye Makes It On '33-Listan' for the Third Time - [...]
ArgusEye Closes €2.8 Million Funding to Accelerate Bioprocessing
ArgusEye Closes €2.8 Million Funding to Accelerate Bioprocessing [...]
ArgusEye introduces AugaOne™ to accelerate downstream bioprocess development
ArgusEye Introduces AugaOne™ to Accelerate Downstream Bioprocess Development [...]
The Countdown Begins: Just Two Months Until the Exciting Launch of AugaOne™!
The Countdown Begins: Just Two Months Until the Exciting Launch [...]
ArgusEye – Among the Top 33 Tech Startups in Sweden, Once Again!
ArgusEye – Among the Top 33 Tech Startups in Sweden, [...]
ArgusEye Signs Agreement with Optronic for Intensified Product Development and Increased Manufacturing Capacity
ArgusEye Signs Agreement with Optronic for Intensified Product Development and [...]
ArgusEye – One of Sweden’s Top Startups 2022
ArgusEye – One of Sweden’s Top Startups 2022 [...]